Case Study: Leading BioSciences achieves Phase 2 clinical trial continuity with Donnelley Financial Solutions' Venue

How Venue’s High Security and Collaborative Design Deliver for Pharma

Leading BioSciences faced a critical challenge when COVID‑19 threatened to halt a Phase 2 clinical trial: a shutdown could have delayed or ended the study. To keep the trial alive, Leading BioSciences turned to Donnelley Financial Solutions and its Venue virtual data room to share and manage clinical trial and patient data remotely.

Donnelley Financial Solutions’ Venue provided an encrypted, HIPAA‑aligned virtual data room with 256‑bit encryption, instant setup and an intuitive interface that let staff at 11 trial sites and independent monitors submit and access records in minutes. With integrated redaction, permissions and collaboration tools, Venue kept the study on track, delivered measurable time and cost savings, and convinced Leading BioSciences to adopt the platform for future studies.

Leading BioSciences

Inge Bear

Chief Development Officer